Skyscape Web Viewer : The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs : Main Index

View All
Barriers to deprescribing Tapering Psychiatric Drugs in Practice Barriers and Facilitators to Deprescribing
Bead counting/weighing Practical Options in Prescribing Gradually Tapering Doses of Antidepressants Practical Options for Prescribing Gradually Tapering Doses
Beneficial effects benzodiazepines and z-drugs Tapering Psychiatric Drugs in Practice antidepressants gabapentinoids Why Deprescribe?
Benzodiazepines
Bipolar disorder Distinguishing Benzodiazepine Withdrawal Symptoms from Return of an Underlying Condition When and Why to Stop Benzodiazepines and Z-Drugs Distinguishing Antidepressant Withdrawal Symptoms from New Onset of a Physical or Mental Health Condition Tapering Benzodiazepines and Z-Drugs in Practice When and Why to Stop Gabapentinoids
Bleeding risks
Boxed warning (black box warn- ing) Protracted Benzodiazepine Withdrawal Syndrome Withdrawal Symptoms from Benzodiazepines and Z-Drugs How to Deprescribe Benzodiazepines and Z-Drugs Safely When and Why to Stop Benzodiazepines and Z-Drugs
British National Formulary (BNF) Other Considerations in Tapering Gabapentinoids Other Considerations in Tapering Benzodiazepines and Z-Drugs Practical Options in Prescribing Gradually Tapering Doses of Antidepressants
Buproprion
Buspirone Other Considerations in Tapering Benzodiazepines and Z-Drugs Buspirone